Trial
NCT01871311
A Phase I Study of Nilontinib and Cetuximab in Patients With Solid Tumors
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Georgetown University
Collaborators
Novartis
Condition
Colorectal Cancer
Intervention
Nilotinib + Cetuximab
Why stopped
Primary investigator left the institution.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-02-08